According to Yagi et al. [70], glucagon may promote colon cancer cell growth by regulating the 5′ adenosine monophosphate-activated protein kinase (AMPK) and mitogen-activated protein kinase (MAPK) pathways. This evidence concerns the gene WNK2 and malignant colon neoplasm.